Thomas K. Weber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Thomas K. Weber has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Tara Sotsky Kent
3 shared publicationsAgnes Miller
2 shared publicationsAnna Bennett
2 shared publicationsPrashanth Sreeramoju
2 shared publicationsAnu G Gaba
Department of Molecular Genetics, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Ullmann 707, New York, NY 10461, USA
1 shared publicationBenjamin Legendre
1 shared publication
Latest Publications
- 31 December 2006
- Published by Elsevier in Cancer Detection Prevention
- Vol. 30 (4) , 333-340
A novel mutation detection approach of hMLH1 and hMSH2 genes for screening of colorectal cancer
- 31 December 2006
- Published by Elsevier in Cancer Detection Prevention
- Vol. 30 (4) , 333-340
A novel mutation detection approach of hMLH1 and hMSH2 genes for screening of colorectal cancer
- 4 April 2005
- Published by Springer Nature in Oncogene
- Vol. 24 (22) , 3657-3668
Modulation of CDK2-AP1 (p12DOC−1) expression in human colorectal cancer
We have previously demonstrated an association between microsatellite instability and decreased CDK2-AP1 (p12DOC-1) expression in human colorectal cancer (CRC) cell lines. In those same studies, induction of CDK2-AP1 expression promoted both cell cycle arrest and apoptosis. The goals of our present study were to better understand the mechanisms leading to reduced CDK2-AP1 expression in microsatellite unstable (MSI) CRC and to study further the effect of CDK2-AP1 modulation on cell proliferation and apoptosis utilizing RNA interference (RNAi) techniques. We used direct sequencing to screen for mutations of the poly (T)8 microsatellite-like region in the 3' end of the CDK2-AP1 gene in 24 CRC cell lines. We then utilized an in vitro human mismatch repair (MMR) recombinant system to assess for correction of the mutation and changes in CDK2-AP1 expression secondary to hMLH1 transfection. We also investigated the effect of CDK2-AP1 modulation in four settings: (1) native CDK2-AP1 absence, (2) endogenous CDK2-AP1 expression, (3) RNAi-induced CDK2-AP1 inhibition and (4) induced CDK2-AP1 over expression. The mutation – del T poly (T)8 – at the 3' end of the CDK2-AP1 gene was found in 3/12 (25%) of MSI CRC cell lines, but in none of the microsatellite stable samples (0/12). Interestingly, when wild-type MMR protein – MLH1 – was induced in an in vitro human recombinant system, the del T poly (T)8 mutation was reversed and CDK2-AP1 expression increased. RNAi-mediated CDK2-AP1 inhibition was associated with decreased apoptosis and increased cell proliferation in CDK2-AP1-non deficient CRC cell lines. We conclude that mutations in the microsatellite-like sequence of the CDK2-AP1 gene in MSI CRC are associated with decreased CDK2-AP1 expression. In addition, modulation of CDK2-AP1 expression in human CRC alters cell proliferation and apoptosis.
- 4 April 2005
- Published by Springer Nature in Oncogene
- Vol. 24 (22) , 3657-3668
Modulation of CDK2-AP1 (p12DOC−1) expression in human colorectal cancer
We have previously demonstrated an association between microsatellite instability and decreased CDK2-AP1 (p12DOC-1) expression in human colorectal cancer (CRC) cell lines. In those same studies, induction of CDK2-AP1 expression promoted both cell cycle arrest and apoptosis. The goals of our present study were to better understand the mechanisms leading to reduced CDK2-AP1 expression in microsatellite unstable (MSI) CRC and to study further the effect of CDK2-AP1 modulation on cell proliferation and apoptosis utilizing RNA interference (RNAi) techniques. We used direct sequencing to screen for mutations of the poly (T)8 microsatellite-like region in the 3' end of the CDK2-AP1 gene in 24 CRC cell lines. We then utilized an in vitro human mismatch repair (MMR) recombinant system to assess for correction of the mutation and changes in CDK2-AP1 expression secondary to hMLH1 transfection. We also investigated the effect of CDK2-AP1 modulation in four settings: (1) native CDK2-AP1 absence, (2) endogenous CDK2-AP1 expression, (3) RNAi-induced CDK2-AP1 inhibition and (4) induced CDK2-AP1 over expression. The mutation – del T poly (T)8 – at the 3' end of the CDK2-AP1 gene was found in 3/12 (25%) of MSI CRC cell lines, but in none of the microsatellite stable samples (0/12). Interestingly, when wild-type MMR protein – MLH1 – was induced in an in vitro human recombinant system, the del T poly (T)8 mutation was reversed and CDK2-AP1 expression increased. RNAi-mediated CDK2-AP1 inhibition was associated with decreased apoptosis and increased cell proliferation in CDK2-AP1-non deficient CRC cell lines. We conclude that mutations in the microsatellite-like sequence of the CDK2-AP1 gene in MSI CRC are associated with decreased CDK2-AP1 expression. In addition, modulation of CDK2-AP1 expression in human CRC alters cell proliferation and apoptosis.
- 18 September 2003
- Published by Springer Nature in Oncogene
- Vol. 22 (40) , 6304-6310
Differential expression of DOC-1 in microsatellite-unstable human colorectal cancer
The precise genetic mechanism of malignant transformation in DNA mismatch repair deficient, microsatellite-unstable colorectal cancer (CRC) has yet to be elucidated. We employed cDNA microarray to identify patterns of gene expression among CRC cell lines and to compare directly lines with and without microsatellite instability. This study was undertaken to test the hypothesis that microsatellite-unstable CRC cell lines demonstrate specific patterns of gene expression that differ significantly from those observed among microsatellite-stable CRC. Multiple differential expression patterns were identified. Genes demonstrating differential expression included deleted-in-oral-cancer-1 (DOC-1), a highly conserved growth suppressor. DOC-1 expression correlated with microsatellite status, with significantly decreased expression in microsatellite-unstable cell lines and constitutive expression in microsatellite-stable cell lines. We also observed alterations in the biologic behavior of p12DOC-1-deficient cell lines, with increased S phase and decreased apoptosis compared to microsatellite-stable (DOC-1+) cell lines. Transfection of p12DOC-1 into SW48, which lacks p12DOC-1 expression, resulted in cell cycle and apoptosis profiles similar to other p12DOC-1+ cell lines. These results support the hypothesis that microsatellite-unstable CRC is characterized by novel patterns of gene expression different from those associated with microsatellite-stable CRC, and demonstrate that p12DOC-1 has tumor suppressor potential in colon epithelial cells.
- 18 September 2003
- Published by Springer Nature in Oncogene
- Vol. 22 (40) , 6304-6310
Differential expression of DOC-1 in microsatellite-unstable human colorectal cancer
The precise genetic mechanism of malignant transformation in DNA mismatch repair deficient, microsatellite-unstable colorectal cancer (CRC) has yet to be elucidated. We employed cDNA microarray to identify patterns of gene expression among CRC cell lines and to compare directly lines with and without microsatellite instability. This study was undertaken to test the hypothesis that microsatellite-unstable CRC cell lines demonstrate specific patterns of gene expression that differ significantly from those observed among microsatellite-stable CRC. Multiple differential expression patterns were identified. Genes demonstrating differential expression included deleted-in-oral-cancer-1 (DOC-1), a highly conserved growth suppressor. DOC-1 expression correlated with microsatellite status, with significantly decreased expression in microsatellite-unstable cell lines and constitutive expression in microsatellite-stable cell lines. We also observed alterations in the biologic behavior of p12DOC-1-deficient cell lines, with increased S phase and decreased apoptosis compared to microsatellite-stable (DOC-1+) cell lines. Transfection of p12DOC-1 into SW48, which lacks p12DOC-1 expression, resulted in cell cycle and apoptosis profiles similar to other p12DOC-1+ cell lines. These results support the hypothesis that microsatellite-unstable CRC is characterized by novel patterns of gene expression different from those associated with microsatellite-stable CRC, and demonstrate that p12DOC-1 has tumor suppressor potential in colon epithelial cells.
- 1 July 2002
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 9 (6) , 532-534
Preoperative Chemoradiation for Rectal Cancer: "Apples & Pears, Tables and Chairs..."
- 1 July 2002
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 9 (6) , 532-534
Preoperative Chemoradiation for Rectal Cancer: "Apples & Pears, Tables and Chairs..."